High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.1M
$3,054,149
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -28.0%
2026-03-20
$54,398
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -28.0%
|
2026-03-20 | $54,398 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-20 | $95,933 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -33.3%
2026-03-20
$47,546
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -33.3%
|
2026-03-20 | $47,546 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2026-03-20 | $122,750 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -76.0%
2026-02-20
$165,410
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -76.0%
|
2026-02-20 | $165,410 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-02-20 | $52,860 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2026-02-20 | $122,750 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2026-01-20 | $122,750 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2026-01-20 | $93,600 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-01-20 | $26,672 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -96.1%
2026-01-20
$333,145
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -96.1%
|
2026-01-20 | $333,145 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-01-20 | $13,704 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -52.6%
2025-12-17
$1,182,984Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -52.6%
|
2025-12-17 | $1,182,984Large | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2025-12-17 | $93,600 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2025-12-17 | $332,040 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-12-17 | $84,070 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -80.4%
2025-12-17
$342,064
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -80.4%
|
2025-12-17 | $342,064 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -61.0%
2025-12-17
$655,362
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -61.0%
|
2025-12-17 | $655,362 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2025-12-17 | $616,843 | M | Form 4 |